Credit: Cytiva.

Emmanuel Abate profile page

President of Genomic Medicine and Head of Sustainability

at Cytiva

Emmanuel Abate is the president of genomic medicine and head of sustainability at Cytiva where he leads the business supporting the discovery, development, and manufacture of viral vector, cell therapy, and nucleic acid-based therapies. He also oversees Cytiva’s sustainability and corporate social responsibility strategy, helping drive initiatives that support customers, associates, and broader societal impact.

Areas of Expertise

Cell Therapy

Viral Vectors

Got a Question for Emmanuel Abate?

Get in touch using the contact form linked here and we'll get back to you shortly.

Content Written By, Reviewed By, or Featuring Emmanuel Abate

Total: 1

Illustration of a blue and pink DNA double helix on a navy background. Part of the helix has been removed, representing gene editing.

Industry Insight

Building Scalable, Reliable AAV Gene Therapy Manufacturing

Cytiva’s Emmanuel Abate explores the FDA’s AMT designation for ELVECTA, the challenges of encapsidated host cell DNA, and how advanced manufacturing platforms could support safer, more scalable gene therapies.